 |
|
|
| |
Changes in the characteristics of hepatitis
C patients treated with direct-acting antivirals from 2014-2017
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting, November 9-13, 2018, San Francisco, CA
Amanda W. Singer1, Krystin Matthews2, Anu Osinusi1, Diana M. Brainard1, Laura Telep1, Anand P. Chokkalingam1
1Gilead Sciences, Foster City, CA; 2The University of Texas Health Sciences Center at Houston, School of Public Health, Austin, TX
|
| |
|
|
|
|
|
